The store will not work correctly when cookies are disabled.
N-benzyl-3-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-amine
ID: ALA4207396
Cas Number: 73376-45-1
PubChem CID: 221104
Max Phase: Preclinical
Molecular Formula: C13H13N5
Molecular Weight: 239.28
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1n[nH]c2c(NCc3ccccc3)ncnc12
Standard InChI: InChI=1S/C13H13N5/c1-9-11-12(18-17-9)13(16-8-15-11)14-7-10-5-3-2-4-6-10/h2-6,8H,7H2,1H3,(H,17,18)(H,14,15,16)
Standard InChI Key: CHNKRFXXARCZRN-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
31.7246 -17.3137 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.7234 -18.1332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4315 -18.5422 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.4297 -16.9048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1383 -17.3101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1431 -18.1287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9231 -18.3771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4005 -17.7120 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.9154 -17.0526 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.1802 -19.1529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4273 -16.0876 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.7183 -15.6812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7159 -14.8640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4243 -14.4580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4222 -13.6416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7127 -13.2343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0039 -13.6494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0095 -14.4644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
7 10 1 0
4 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 239.28 | Molecular Weight (Monoisotopic): 239.1171 | AlogP: 2.27 | #Rotatable Bonds: 3 |
Polar Surface Area: 66.49 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.92 | CX Basic pKa: 1.76 | CX LogP: 1.68 | CX LogD: 1.68 |
Aromatic Rings: 3 | Heavy Atoms: 18 | QED Weighted: 0.74 | Np Likeness Score: -1.48 |
References
1. Cherukupalli S, Hampannavar GA, Chinnam S, Chandrasekaran B, Sayyad N, Kayamba F, Reddy Aleti R, Karpoormath R.. (2018) An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold., 26 (2): [PMID:29273417] [10.1016/j.bmc.2017.10.012] |